共 50 条
- [45] Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1075 - 1079
- [49] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial Diabetes Therapy, 2018, 9 : 1253 - 1267